L.J. Altfest & Co’s Immunovant IMVT Stock Holding History

L.J. Altfest & Co’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,867	Closed	-$454K	–	353
2025 Q4	$454K	Buy	17,867 +141	+0.8%	+$3.14K	0.05%	239
2025 Q3	$286K	Buy	+17,726	New	+$287K	0.03%	295

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

L.J. Altfest & Co's IMVT Position: Q1 2026 in Review

L.J. Altfest & Co sold out of Immunovant (IMVT) in Q1 2026, closing a stake of 17,867 shares — an estimated $454K sold.

L.J. Altfest & Co first reported a position in IMVT in Q3 2025 and held it in 2 quarters. The position peaked at $454K in Q4 2025. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

L.J. Altfest & Co reported no remaining Immunovant position as of Q1 2026 after selling out during the quarter.
L.J. Altfest & Co sold 17,867 Immunovant shares in Q1 2026, an estimated $454K.
L.J. Altfest & Co first reported a position in Immunovant in Q3 2025 and held it in 2 quarters.
L.J. Altfest & Co's Immunovant position peaked at $454K in Q4 2025.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on L.J. Altfest & Co's 13F filing for Q1 2026, filed 28 Apr 2026.